It’s with great regret that we have decided to cancel Venturefest Oxford 2020 due to COVID-19 concerns. While this decision comes at a time of global uncertainty, we take the safety and health of our attendees, staff and community very seriously.
We believe that one of the strengths of Venturefest Oxford is the ability to bring different groups of people together to engage, interact and network. At this time, we do not think that we do justice to this event by delivering it in a different manner.
Venturefest Oxford will be back in 2021, with a date and venue to be confirmed later this year.
Thank you for your continued support and we look forward to seeing you in 2021.
When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE
Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE
Given the recent wide-ranging consultation on R&D tax relief, it was probably inevitable that reform of the R&D tax relief schemes (now over 20 years old) would be announced in the Chancellor’s Budget on 27 October 2021, although these announcements were headline only with more details to follow. READ MORE